Serin Formulations Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 23 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.50 M
- Satisfied Charges ₹ 1.01 Cr
- Revenue Growth 3.15%
- Profit Growth 5.09%
- Ebitda -0.16%
- Net Worth 16.41%
- Total Assets -0.12%
About Serin Formulations
Serin Formulations Private Limited (SFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 December 2001 and has a history of 23 years and one month. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹6.50 M. The company has closed loans amounting to ₹1.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vejju Rao, Kodali Shankar, Vannem Raju, and One other member serve as directors at the Company.
Company Details
-
Location
Rangareddy, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231TG2001PTC038249
-
Company No.
038249
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
21 Dec 2001
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
What products or services does Serin Formulations Private Limited offer?
Serin Formulations Private Limited offers a wide range of products and services, including Floor Cleaner, Liquid Floor Cleaner, Ultrasound Accessories, ECG Gel, Surface Cleaner, Cleaning Gel, Diagnostic Imaging Accessories, Diagnostic Medical Imaging Equipment, Tile Cleaner, Antibiotic Tablets & Capsules.
Who are the key members and board of directors at Serin Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vejju Rao
|
Managing Director | 21-Dec-2001 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Kodali Shankar
|
Whole-Time Director | 21-Dec-2001 | Current |
|
Vannem Raju
|
Director | 21-Dec-2001 | Current |
|
Naga Pasam
|
Director | 21-Dec-2001 | Current |
Financial Performance of Serin Formulations.
Serin Formulations Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.15% increase. The company also saw a slight improvement in profitability, with a 5.09% increase in profit. The company's net worth Soared by an impressive increase of 16.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Serin Formulations?
In 2023, Serin Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Amaze Pharmaceuticals LimitedVejju Rao is a mutual person
Charges (Loans)
₹6.50 M
₹10.07 M
Charges Breakdown by Lending Institutions
- Bank Of India : 0.65 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2022 | Bank Of India | ₹6.50 M | Open |
| 29 May 2019 | Hdfc Bank Limited | ₹7.57 M | Satisfied |
| 23 May 2002 | Bank Of India | ₹2.50 M | Satisfied |
How Many Employees Work at Serin Formulations?
Serin Formulations has a workforce of 30 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Serin Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Serin Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
